EFFECTS OF ICRF-159 ON BURKITT-LYMPHOMA CELLS INVITRO

被引:0
|
作者
WHEELER, RH [1 ]
RUDDON, RW [1 ]
机构
[1] UNIV MICHIGAN,MED CTR,ANN ARBOR,MI 48109
来源
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1977年 / 18卷 / MAR期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:168 / 168
页数:1
相关论文
共 50 条
  • [21] CIS-DICHLORODIAMMINEPLATINUM(II) WITH AND WITHOUT ICRF-159 IN NON-HODGKINS LYMPHOMA
    CORDER, MP
    WIESENFELD, M
    MAGUIRE, LC
    LEIMERT, JT
    PANTHER, SK
    CANCER TREATMENT REPORTS, 1980, 64 (2-3): : 301 - 304
  • [22] BURKITT-LYMPHOMA IN GABON
    MORENO, JL
    OBAME, HN
    NARDOU, M
    GENDREL, D
    ANNALES DE PEDIATRIE, 1994, 41 (04): : 253 - 258
  • [23] RADIOTHERAPY COMBINED WITH ICRF-159 (NSC-129943)
    RHOMBERG, WU
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1978, 4 (1-2): : 121 - 126
  • [24] BURKITT-LYMPHOMA OF THE TESTIS
    ROZANSKI, TA
    CASTILLO, IC
    MILITARY MEDICINE, 1994, 159 (04) : 362 - 363
  • [25] BURKITT-LYMPHOMA IN GERMANY
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1970, 95 (19) : 1080 - &
  • [26] SYNERGISM OF ICRF-159 AND RADIOTHERAPY IN TREATMENT OF EXPERIMENTAL TUMORS
    HELLMANN, K
    MURKIN, GE
    CANCER, 1974, 34 (04) : 1033 - 1039
  • [27] THE MUTAGENIC ACTIVITY OF RAZOXANE (ICRF-159) - AN ANTICANCER AGENT
    ALBANESE, R
    WATKINS, PA
    BRITISH JOURNAL OF CANCER, 1985, 52 (05) : 725 - 731
  • [28] BLOOD CLEARANCE OF ICRF-159 (NSC-129943)
    FIELD, EO
    HELLMANN, K
    MAURO, F
    CANCER CHEMOTHERAPY REPORTS PART 1, 1971, 55 (05): : 527 - &
  • [29] INVITRO CYTOKINETIC AND CYTO-TOXIC EFFECTS OF AT-125 (ACI-IVIN) IN BURKITT-LYMPHOMA CELLS
    CLAUW, DJ
    WHEELER, RH
    HUDSON, JL
    LOVETT, EJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 305 - 305
  • [30] FROM BURKITT-LYMPHOMA TO BURKITT CELLS - CLINICAL, IMMUNOLOGICAL AND GENETIC DATA
    SCHAISON, G
    BERGER, R
    PREUDHOMME, JL
    FLANDRIN, G
    BOIRON, M
    SEMAINE DES HOPITAUX, 1983, 59 (07): : 496 - 497